ResMed (RMD) stock traded sideways late Thursday after the medtech company reported adjusted earnings of $2.43 per share on $1.28 billion in fiscal second-quarter sales.
↑ X NOW PLAYING How To Buy Stocks: Double-Bottom Chart PatternAnalysts polled by FactSet expected the CPAP maker to earn $2.32 per share and $1.27 billion in sales. Sales increased 10%, while earnings rose more than 29%.
ResMed didn't provide guidance for the year. The Street projected EPS of $9.41 and $5.12 billion in sales.
In after-hours trades, ResMed stock was roughly flat at 257.65. Shares broke out of a double-bottom base with a buy point at 252.36, according to MarketSurge.
More to follow.
YOU MAY ALSO LIKE:
Thermo Fisher Scientific Gaps Up And Nears A Buy Point On Strong Earnings Beat
Teva Stock Dives 14%. 'We're Victims Of Our Own Success,' Says CEO.
Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks
Follow Premarket And After-The-Open Action With IBD Experts
Find Today's Best Growth Stocks To Watch With IBD 50
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.